Novo Nordisk (NVO)
46.60
-0.91 (1.92%)
Upcoming Events
Latest Headlines
BofA Securities Reiterates Neutral Rating on Novo Nordisk (NOVOB:DC) (NVO)
September 4, 2026 6:07 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Aug 31
August 31, 2026 9:11 AM - SEC Filing
Deutsche Bank cuts Novo Nordisk to Sell after earnings, shares dip
August 27, 2026 8:59 AM - StreetInsider
Novo Nordisk seeks China approval for oral Wegovy drug
August 27, 2026 8:27 AM - StreetInsider
Deutsche Bank Downgrades Novo Nordisk (NOVOB:DC) (NVO) to Sell
August 27, 2026 4:23 AM - StreetInsider
PepsiCo Scraps Coverage of Weight-Loss Drugs for Employees - Bloomberg
August 25, 2026 1:54 PM - StreetInsider
Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK275 at JPMorgan
August 25, 2026 4:28 AM - StreetInsider
Novo Resources Releases Updated Corporate Presentation
August 24, 2026 5:31 PM - Globe NewsWire
Form 6-K NOVO NORDISK A S For: Aug 24
August 24, 2026 10:50 AM - SEC Filing
A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.
August 18, 2026 12:57 PM - Globe NewsWire
Hims & Hers CEO pushes back against FTC suit, says "we are active disruptors"
August 18, 2026 11:05 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Aug 17
August 18, 2026 6:05 AM - SEC Filing
Berenberg Downgrades Novo Nordisk (NVO) to Hold
August 12, 2026 3:06 AM - StreetInsider
Berenberg Downgrades Novo Nordisk (NOVOB:DC) (NVO) to Hold
August 12, 2026 3:06 AM - StreetInsider
Novo Nordisk launches once-weekly basal insulin Awiqli nationwide
August 11, 2026 9:13 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Aug 10
August 10, 2026 10:47 AM - SEC Filing
Form 6-K NOVO NORDISK A S For: Aug 06
August 10, 2026 10:42 AM - SEC Filing
Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK310 at Citi
August 7, 2026 4:56 AM - StreetInsider
Novo Nordisk (NVO) PT Raised to $47 at BMO Capital
August 6, 2026 7:50 AM - StreetInsider
Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK310 at Barclays
August 6, 2026 4:56 AM - StreetInsider
Novo Nordisk wins Dutch court order against Ceban over semaglutide
August 5, 2026 10:36 AM - StreetInsider
Novo Nordisk tumbles as Wegovy sales miss, trial setback overshadow raised outlook
August 5, 2026 6:46 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Jun 30
August 4, 2026 5:24 PM - SEC Filing
Form 6-K NOVO NORDISK A S For: Aug 04
August 4, 2026 1:40 PM - SEC Filing
Novo Nordisk raises 2026 outlook on stronger GLP-1 sales
August 4, 2026 12:34 PM - StreetInsider
Novo Nordisk (NVO) call put ratio 2.5 call to 1 put into quarter results
August 4, 2026 11:23 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Aug 04
August 4, 2026 10:39 AM - SEC Filing
Novo Nordisk (NVO) call put ratio 1.9 calls to 1 put into quarter results
August 4, 2026 4:40 AM - StreetInsider
Novo Nordisk (NVO) call put ratio 1 call to 1 put into quarter results
August 3, 2026 11:00 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Jul 31
July 31, 2026 8:55 AM - SEC Filing
Novo Nordisk stock tumbles 10% as key trial misses goal
July 31, 2026 8:11 AM - StreetInsider
Novo Nordisk's ziltivekimab fails to reduce heart risk in ZEUS trial
July 31, 2026 7:26 AM - StreetInsider
Novo Nordisk must face fraud lawsuit over CagriSema trial, judge rules
July 28, 2026 12:54 PM - StreetInsider
Form 6-K NOVO NORDISK A S For: Jul 27
July 27, 2026 8:08 AM - SEC Filing
Lilly to file for next-gen obesity drug approval in early 2027
July 23, 2026 10:54 AM - StreetInsider
Novo Nordisk sues Eli Lilly in high-stakes GLP-1 advertising feud
July 21, 2026 7:53 AM - StreetInsider
Novo Nordisk sues Eli Lilly over weight-loss drug ads
July 21, 2026 7:36 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Jul 20
July 21, 2026 6:04 AM - SEC Filing
Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK330 at Citi
July 20, 2026 5:07 AM - StreetInsider
Novo Nordisk wins EU approval for Wegovy pill and new injection
July 15, 2026 11:53 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Jul 13
July 13, 2026 9:24 AM - SEC Filing
Form 6-K NOVO NORDISK A S For: Jul 06
July 6, 2026 7:00 AM - SEC Filing
Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK300 at HSBC
July 6, 2026 1:32 AM - StreetInsider
Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK285 at Jefferies
June 30, 2026 8:14 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Jun 29
June 29, 2026 4:16 PM - SEC Filing
Sandoz submits generic obesity drug applications to FDA
June 29, 2026 6:14 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Jun 22
June 24, 2026 6:03 AM - SEC Filing
Form 11-K NOVO NORDISK A S For: Dec 31
June 22, 2026 6:02 AM - SEC Filing
Form 11-K NOVO NORDISK A S For: Dec 31
June 22, 2026 6:02 AM - SEC Filing
Oral Wegovy reaches 33% of total prescriptions by May
June 18, 2026 5:47 AM - StreetInsider
Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says
June 17, 2026 11:15 AM - StreetInsider
Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK325 at Berenberg
June 17, 2026 4:27 AM - StreetInsider
Novo Nordisk to seek approval soon to sell Wegovy pill in China
June 16, 2026 2:02 AM - StreetInsider
Form 6-K NOVO NORDISK A S For: Jun 15
June 15, 2026 7:43 AM - SEC Filing
Leerink highlights drug demand rebound after Memorial Day
June 12, 2026 2:42 PM - StreetInsider
Novo Nordisk gets UK approval for daily Wegovy weight loss pill
June 11, 2026 11:13 AM - StreetInsider
Oral GLP-1 obesity drugs see rapid early adoption, Bernstein survey shows
June 9, 2026 2:31 PM - StreetInsider
Belltopper Gold Project Mineral Resource
June 8, 2026 11:04 PM - Globe NewsWire
Form 6-K NOVO NORDISK A S For: Jun 08
June 8, 2026 9:49 AM - SEC Filing
Novo Nordisk (NVO) call put ratio 2.1 calls to 1 put
June 8, 2026 3:09 AM - StreetInsider
Full Article List
